JAMA Oncology Author Interviews
Podcast de JAMA Network
Empieza 7 días de prueba
$99.00 / mes después de la prueba.Cancela cuando quieras.
Más de 1 millón de oyentes
Podimo te va a encantar, y no estás solo/a
Rated 4.7 in the App Store
Acerca de JAMA Oncology Author Interviews
Interviews with authors of articles from JAMA Oncology. JAMA Oncology is the definitive journal for scientists, clinicians, and trainees in the field of oncology worldwide. Our original, innovative, and timely scientific and educational content provides a deeper understanding of cancer pathogenesis and recent treatment advances for our readers. JAMA Oncology aims to effectively convey the findings of important clinical research, major scientific breakthroughs, actionable discoveries, and state-of-the-art treatment pathways to the oncology community. Our goal is that successful communication of new knowledge will ultimately translate to clinical benefit for people living with and surviving cancer.
Todos los episodios
126 episodios
Interview with Thorir Einarsson Long, MD, PhD, and Ola Landgren, MD, PhD, authors of New Definition of Light Chain Monoclonal Gammopathy of Undetermined Significance. Hosted by Vivek Subbiah, MD. Related Content: * New Definition of Light Chain Monoclonal Gammopathy of Undetermined Significance [https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2025.1285?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links]
Interview with Shruti Gupta, MD, MPH, author of Intravenous Magnesium and Cisplatin-Associated Acute Kidney Injury. Hosted by Vivek Subbiah, MD. Related Content: * Intravenous Magnesium and Cisplatin-Associated Acute Kidney Injury [https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2025.0756?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links]
Interview with Jennifer M. Yeh, PhD, and Lisa R. Diller, MD, authors of Accelerated Aging in Survivors of Childhood Cancer—Early Onset and Excess Risk of Chronic Conditions. Hosted by Vivek Subbiah, MD. Related Content: * Accelerated Aging in Survivors of Childhood Cancer—Early Onset and Excess Risk of Chronic Conditions [https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2025.0236?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links] * On Accelerated Aging—A Phenomenon in Survivors of Childhood Cancer [https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2025.0130?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links]
Interview with Anand P. Jillella, MD, author of Academic-Community Partnership and Deaths in Promyelocytic Leukemia: The Nonrandomized ECOG-ACRIN EA9131 Trial. Hosted by Vivek Subbiah, MD. Related Content: * Academic Community Partnership in Acute Promyelocytic Leukemia and Early Mortality [https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2024.7033?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links]
Interview with Michael A. Postow, MD, author of Intracranial Outcomes of Ipilimumab and Nivolumab in Melanoma Brain Metastases After Progression on Anti–PD-1 Therapy. Hosted by Vivek Subbiah, MD. Related Content: * Intracranial Outcomes of Ipilimumab and Nivolumab in Melanoma Brain Metastases After Progression on Anti–PD-1 Therapy [https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2024.6168?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links]
Rated 4.7 in the App Store
Empieza 7 días de prueba
$99.00 / mes después de la prueba.Cancela cuando quieras.
Podcasts exclusivos
Sin anuncios
Podcast gratuitos
Audiolibros
20 horas / mes
